Lidocaine Hydrochloride
- Product NDC
- 73293-0003
- Requested package NDC
- 73293-0003-2
- 11-digit product format
- 732930003
- Labeler code
- 73293
- Product ID
- 73293-0003_4711fd53-dad3-f117-e063-6394a90a8d3d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lidocaine Hydrochloride
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Huons Co., Ltd.
- Application
- ANDA212821
- Marketing category
- ANDA
- Marketing start
- 2023-06-15
- Substance
- LIDOCAINE HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212821-001 | LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | 1% | INJECTABLE / INJECTION | AP | 2020-05-07 | |
| A212821-002 | LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | 2% | INJECTABLE / INJECTION | AP | 2023-06-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212821-001 | AP |
| A212821-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212821-001 | LIDOCAINE HYDROCHLORIDE | 1% | INJECTABLE / INJECTION | AP | 2020-05-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A212821-002 | LIDOCAINE HYDROCHLORIDE | 2% | INJECTABLE / INJECTION | AP | 2023-06-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212821-001 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A212821-002 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Precision Dose, Inc. | 27b6ef54-a093-2bef-e063-6394a90a7912 | 2025-12-29 | Warnings, Adverse reactions | 212821 ANDA212821 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Brookfield Pharmaceuticals, LLC. | e824ba5b-3289-5ad4-e053-2995a90acc20 | 2025-11-27 | Warnings, Adverse reactions | 212821 ANDA212821 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC. | 42531a38-7cff-de16-e063-6394a90a18d8 | 2025-10-29 | Warnings, Adverse reactions | 212821 ANDA212821 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Huons Co., Ltd. | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 2025-05-09 | Warnings, Adverse reactions | 212821 ANDA212821 73293-0003-2 73293-0003 73293000302 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Novagenix Labs LLC | 7567ffb5-953a-4be9-9a02-c5a50dcd9306 | 2025-03-12 | Warnings, Adverse reactions | 212821 ANDA212821 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | McKesson Corporation dba SKY Packaging | e1eabd6b-9bb8-646f-e053-2a95a90a7b83 | 2025-02-20 | Warnings, Adverse reactions | 212821 ANDA212821 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lidocaine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 20 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73293-0003-1 | Lidocaine Hydrochloride | 5 mL in 1 VIAL | SOLUTION | 5 | 11 | |
| 73293-0003-2 | Lidocaine Hydrochloride | 10 in 1 BOX | SOLUTION | 10 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 73293-0003 | LIDOCAINE HYDROCHLORIDE SOLUTION [HUONS CO., LTD.] | 10 | Current NDC, 2 package rows | 20240328_8ec2d256-fc4f-44f6-bee2-eef2bf3bf580.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1737566 | lidocaine HCl 1 % in 5 ML Injection | PSN | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1010033 | lidocaine HCl 1 % Injectable Solution | PSN | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1737761 | lidocaine HCl 2 % in 5 ML Injection | PSN | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1010671 | lidocaine HCl 2 % Injectable Solution | PSN | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1737566 | 5 ML lidocaine hydrochloride 10 MG/ML Injection | SCD | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1737761 | 5 ML lidocaine hydrochloride 20 MG/ML Injection | SCD | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1010033 | lidocaine hydrochloride 10 MG/ML Injectable Solution | SCD | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1010671 | lidocaine hydrochloride 20 MG/ML Injectable Solution | SCD | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1737566 | lidocaine HCl 1 % per 5 ML Injection | SY | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1737761 | lidocaine HCl 100 MG per 5 ML Injection | SY | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1737761 | lidocaine HCl 2 % per 5 ML Injection | SY | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1737566 | lidocaine HCl 50 MG per 5 ML Injection | SY | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1010033 | lidocaine hydrochloride 1 % Injectable Solution | SY | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
| 1010671 | lidocaine hydrochloride 2 % Injectable Solution | SY | 8ec2d256-fc4f-44f6-bee2-eef2bf3bf580 | 11 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 73293-0003-2 | 73293000302 | 10 VIAL in 1 BOX (73293-0003-2) / 5 mL in 1 VIAL (73293-0003-1) | 10 vial | 2023-06-16 | No | No | Current |